RecruitingCannabisAbuse LiabilityExperimental Pain in Healthy Human Participants
Repeated CBD Administration and Cannabis Outcomes
Eligible age
18–55 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This outpatient study examines how cannabidiol (CBD) affects the behavioral and pain-relieving effects of cannabis.
Sponsor: Hannah Harris
You may qualify if…
- ✓ English-speaking, literate adults,
- ✓ Male or female,
- ✓ Between the ages of 18-55,
- ✓ Body Mass Index from 18.5-32.0 kg/m2,
- ✓ Not currently seeking treatment for cannabis or drug use,
- ✓ Able to provide written informed consent and perform all study procedures,
- ✓ If female, a negative pregnancy test and use of an effective form of contraception during study participation (e.g., oral contraceptive, abstinence, barrier method),
- ✓ Negative urine drug test for drugs of abuse (other than cannabis) prior to every Laboratory Session, and
You may not qualify if…
- ✕ Physiologic drug dependence on opioids, benzodiazepines, barbiturates, and/or alcohol that would require medical management,
- ✕ Clinically significant acute medical problem (e.g., infection) or chronic medical problem requiring daily medication or ongoing medical care (e.g., hypertension, cardiovascular disease, diabetes, respiratory disorders \[e.g., asthma, COPD\]),
- ✕ Current or past history of major psychiatric disorder that would limit ability to participate in the study,
- ✕ Use of cannabis exclusively for medical reasons (no recreational use reported),
- ✕ Current, unrelenting chronic pain that prevents participation (i.e., unable to sit in chair for 8 hours),
- ✕ Currently using daily prescription medications to manage medical conditions or any drug that could interfere with the study, including potent CYP2C9, CYP3A4, or CYP2C19 inducers,
- ✕ Clinically significant abnormal ECG (as determined by study physician/cardiologist),
- ✕ Clinically significant abnormal laboratory findings,
Where it's recruiting
Kentucky
Lexington
Source: ClinicalTrials.gov · NCT07434895 · last updated 2026-08-12